» Articles » PMID: 39741142

Power-free Plasma Separation Based on Negative Magnetophoresis for Rapid Biochemical Analysis

Overview
Date 2024 Dec 31
PMID 39741142
Authors
Affiliations
Soon will be listed here.
Abstract

We present a versatile platform for label-free magnetic separation of plasma, tailored to accommodate diverse environments. This innovative device utilizes an advanced long-short alternating double Halbach magnetic array, specifically engineered for optimal magnetic separation. The array's adaptability allows for seamless integration with separation channels of varying sizes, enabling static separation of whole blood. The platform has a highly flexible processing throughput, spanning from 100 μL to 3 mL per separation cycle without sacrificing separation efficiency. A key aspect of this device is its power-free operation throughout the separation process, obviating the complexity of conventional separation devices. Its effectiveness is demonstrated by the extraction of 40 μL of plasma from 100 μL of rat whole blood within 8 min. The separated plasma proved effective for subsequent analysis of antibody concentration and size in the separated plasma for pharmacokinetic investigations, yielding results on par with those obtained via centrifugation. Furthermore, the device's high-throughput capability was validated using human whole blood, achieving 3 mL of plasma separation in just 1 min. In a follow-up study on COVID-19 IgG antibody detection, the results matched those from centrifugation. The device demonstrates a separation efficiency of 99.9% for cells larger than 1 μm in both rat and human blood samples, with a plasma recovery rate of 72.7%. In summary, our magnetic separation device facilitates rapid plasma extraction from whole blood, with a capacity of up to 3 mL per minute in human blood, without compromising subsequent plasma-based analyses, thereby highlighting its broad applicability across diverse settings.

References
1.
Tripathi S, Kumar Y, Agrawal A, Prabhakar A, Joshi S . Microdevice for plasma separation from whole human blood using bio-physical and geometrical effects. Sci Rep. 2016; 6:26749. PMC: 4899686. DOI: 10.1038/srep26749. View

2.
Ulum M, Maylina L, Noviana D, Wicaksono D . EDTA-treated cotton-thread microfluidic device used for one-step whole blood plasma separation and assay. Lab Chip. 2016; 16(8):1492-504. DOI: 10.1039/c6lc00175k. View

3.
Subasic C, Simpson F, Minchin R, Kaminskas L . A PEGylated liposomal formulation of prochlorperazine that limits brain exposure but retains dynamin II activity: A potential adjuvant therapy for cancer patients receiving chemotherapeutic mAbs. Nanomedicine. 2024; 56:102733. DOI: 10.1016/j.nano.2024.102733. View

4.
Liu Y, Zhao W, Cheng R, Harris B, Murrow J, Hodgson J . Fundamentals of integrated ferrohydrodynamic cell separation in circulating tumor cell isolation. Lab Chip. 2021; 21(9):1706-1723. PMC: 8102387. DOI: 10.1039/d1lc00119a. View

5.
Urdea M, Penny L, Olmsted S, Giovanni M, Kaspar P, Shepherd A . Requirements for high impact diagnostics in the developing world. Nature. 2006; 444 Suppl 1:73-9. DOI: 10.1038/nature05448. View